@FiercePharma: AbbVie shares fall in first day of 'when-issued' trading. Story | Follow @FiercePharma
> Cardiome Pharma ($CRME) will pony up $20 million to Merck & Co. ($MRK) to settle issues over a heart drug they were partnering on. Story
> Boehringer Ingelheim is now defending itself against hundreds of lawsuits tied to bleeding episodes, some fatal, in patients taking its blood thinner Pradaxa. Story
> Canadian company QLT has its last product for sale--an experimental treatment for a disease that can cause blindness--and it's valuing the product at $750 million. Item
> Indian officials expect the prices of 650 commonly used drugs to fall by up to 15% now that the government has set price controls. Story
> Executives with two supermarkets in Lexington, KY, that cater to Hispanics admitted to smuggling drugs in from Mexico and selling them at their stores. Release
@FierceMedDev: Exact Sciences heads to the FDA with cancer diagnostic. Story | Follow @FierceMedDev
@MarkHFierce: MIT's Robert Langer is at it again--using porcupine quills as a model for next-generation medical device needles. More | Follow @MarkHFierce
@DamianFierce: The effort to delay the medical device tax has picked up some Democratic support. Report | Follow @DamianFierce
> Japan's regulators approve Thoratec's HeartMate II pump. News
> India lures med tech manufacturing interest. Story
> Covidien's blood monitor will ship with GE's infant warmers. Item
Biotech News
@FierceBiotech: GSK employs mobile phones to up vaccination rates in Africa. Story | Follow @FierceBiotech
@JohnCFierce: Sofinnova reaps $312M for its dedicated life sciences fund. Wished we saw more of these. News | Follow @JohnCFierce
> Teva chief Levin inks $376M deal on Xenon pain program. Article
> Isis grabs $31M in quick AstraZeneca cash during busy dealmaking round. Report
> Exclusive: Cerulean hauls in $13M, revs up deal talks as it nears PhIIb cancer data. News
Biotech Research News
> New molecule opens door to lymphoma combination therapy. News
> Seattle Genetics' next-gen antibody-drug conjugate tackles leukemia in the lab. Report
> Preclinical data snags GlaxoSmithKline's attention in $335M cancer immunotherapy deal. Article
> MicroRNAs could heal broken hearts. Item
Pharma Manufacturing News
> Novo selling Bangladeshi-made insulin after plant fires up. Story
> Congress investigating compounding pharmacy trade group. Item
> Endo reports oversized problem with oversized pain meds. Article
> Pharma files lawsuit against California drug-disposal law. News
And Finally... The consumer health side of GlaxoSmithKline ($GSK) has set up a smoking-cessation website to market products such as patches, lozenges and nicotine-laced gum. Item